IRIS
BUCCI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.514
EU - Europa 5.283
AS - Asia 4.194
Continente sconosciuto - Info sul continente non disponibili 503
SA - Sud America 426
AF - Africa 68
OC - Oceania 6
Totale 16.994
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.387
SG - Singapore 1.790
IT - Italia 1.417
CN - Cina 1.113
IE - Irlanda 581
DE - Germania 527
SE - Svezia 492
UA - Ucraina 485
FR - Francia 465
RU - Federazione Russa 460
VN - Vietnam 391
GB - Regno Unito 378
TR - Turchia 342
BR - Brasile 339
FI - Finlandia 205
IN - India 203
HK - Hong Kong 95
CA - Canada 70
BD - Bangladesh 59
PL - Polonia 54
ES - Italia 44
MX - Messico 40
NL - Olanda 39
AR - Argentina 37
JP - Giappone 29
BE - Belgio 26
ZA - Sudafrica 24
MY - Malesia 23
ID - Indonesia 22
IQ - Iraq 19
AT - Austria 18
EC - Ecuador 17
KR - Corea 15
CH - Svizzera 13
IL - Israele 13
IR - Iran 13
LT - Lituania 12
PK - Pakistan 12
EG - Egitto 11
GR - Grecia 11
VE - Venezuela 11
AL - Albania 9
CO - Colombia 9
CZ - Repubblica Ceca 9
TH - Thailandia 9
EU - Europa 8
KE - Kenya 8
SA - Arabia Saudita 8
UZ - Uzbekistan 7
ET - Etiopia 6
PH - Filippine 6
AU - Australia 5
JM - Giamaica 5
MA - Marocco 5
PT - Portogallo 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DK - Danimarca 4
EE - Estonia 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
KZ - Kazakistan 3
QA - Qatar 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
Totale 16.496
Salva come PNG Salva come JPEG
Città #
Singapore 1.301
Chandler 720
San Jose 720
Jacksonville 568
Dublin 562
Ashburn 483
Dallas 383
Beijing 305
Munich 289
Princeton 254
Southend 222
Izmir 197
Los Angeles 192
The Dalles 163
New York 161
Nanjing 157
Santa Clara 147
Ho Chi Minh City 135
Council Bluffs 126
Ann Arbor 119
Wilmington 111
Pescara 106
Helsinki 104
Hanoi 98
Dearborn 97
Cambridge 93
Chieti 93
Milan 88
Hong Kong 78
Boardman 72
Tongling 70
Nanchang 63
Altamura 62
Rome 62
Moscow 53
São Paulo 49
Houston 47
Buffalo 45
Orem 44
Woodbridge 40
Redondo Beach 37
Shenyang 35
Warsaw 32
Brooklyn 31
Denver 31
Hebei 31
Tianjin 31
Foggia 30
Washington 30
Hefei 27
Chennai 25
London 25
Nuremberg 25
Tokyo 25
Brussels 24
Chicago 24
Da Nang 24
Atlanta 23
Jinan 23
Montreal 23
Frankfurt am Main 22
Phoenix 21
Toronto 21
Boston 20
Haiphong 19
Kunming 19
Poplar 19
Stockholm 19
Florence 18
Mexico City 18
Amsterdam 17
Bologna 17
Norwalk 17
Johannesburg 16
Manchester 16
Zhengzhou 16
Turku 15
Grevenbroich 14
Hangzhou 14
Rio de Janeiro 14
Biên Hòa 13
Ningbo 13
Auburn Hills 12
Changsha 12
Jiaxing 12
Mumbai 12
Naples 12
Orange 12
San Francisco 12
Seattle 12
Guangzhou 11
Seoul 11
Kraków 10
Kuala Lumpur 10
San Mateo 10
Taizhou 10
Ankara 9
Bari 9
Charlotte 9
Avellino 8
Totale 9.806
Salva come PNG Salva come JPEG
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 557
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 339
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 254
MicroRNA profiling in migraine without aura: Pilot study 254
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 230
A unique microRNA signature associated with plaque instability in humans. 209
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 183
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 176
Linee guida cliniche per la prevenzione della cardiopatia ischemica nella ipercolesterolemia familiare: una patologia sotto-diagnosticata e sotto-trattata. Consensus. 169
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 167
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 167
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 167
VALUTAZIONE FUNZIONALE DELL'ATLETA: RAPPORTI TRA VO2 MAX E COMPOSIZIONE CORPOREA 166
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 165
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 163
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 163
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 160
Uneven accuracy of home blood pressure measurement: a multi-centric survey 160
A unique microRNA signature associated with ischemic stroke in humans 157
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 155
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 155
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 155
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 153
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 152
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 145
Ipertensione arteriosa ed algosensibilità muscolare 144
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 143
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 143
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 143
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 142
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 141
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 141
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 139
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 139
COVID-19 and RAS: Unravelling an Unclear Relationship 137
Risultati immediati ed a lungo termine della rivascolarizzazione coronarica con PTCA con carattere ad autoperfusione vs PTCA con impianto di stent intracoronarico. 136
A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of Covid-19. 136
Association between 5-lipoxygenase expression and plaque instability in humans. 136
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 135
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 134
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 133
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 133
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 133
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 132
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 131
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 131
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 130
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 129
The (K+)ey of the problem 129
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 129
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 128
Single coronary artery with a right origin: angiography identification of the R-II subgroup] 127
[ANALYSIS OF COSTS AND RESULTS OF PROSTAGLANDIN (PGE1 ALPHA-CYCLODESTRIN) THERAPY OF PERIPHERAL ARTERIAL DISEASES] 127
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 125
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 125
PROGETTO DI SCREENING SU 24.000 SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI. 125
uFollow-Up clinico di un gruppo di pazienti sottoposti a PTCA con impianto di stent intracoronarico. 124
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 124
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 123
DISAGREEMENT AMONG THE MAIN ALGORITHMS FOR CARDIOVASCULAR RISK ESTIMATION IN PATIENTS STRATIFICATION AND IN THEIR CORRELATION WITH ARTERIAL STIFFNESS 123
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 122
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 122
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 121
Impact of hypertension on somatic pain sensitivity in chronic headache 121
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 120
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 119
Cardiovascular risk factor control in common clinical practice in a sample of patients in secondary prevention representative of the Abruzzo population 119
Artrite reumatoide ed aumentato rischio cardiovascolare: impatto delle differenti terapie farmacologiche
 [Rheumatoid arthritis and increased cardiovascular risk: role of the different pharmacological therapies] 119
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 116
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes 116
Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia 116
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 114
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 113
Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection 113
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 112
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 112
Cardiovascular risk awareness: what does patient feel? 112
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 110
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 110
Cost-effectiveness of statins in primary and secondary prevention of cardiovascular event 109
Muscle pain sensitivity in hypertensive patients with and without chronic pain 109
Possible indication of coronary risk trough discriminant functions. 108
Hypertension modulates miR-145 expression in human atherosclerotic plaques 107
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 106
Long-term positivity to SARS-Cov-2: a clinical case of Covid-19 with persistent evidence of infection 106
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 105
Effect of evolocumab or ezetimibe added to moderate- Or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: The LAPLACE-2 randomized clinical trial 105
Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients 104
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 103
Effects of lifestyle treatment on patients with metabolic syndrome and non-alcoholic hepatic steatosis evaluated with an ultrasonographic and elastographic approach 103
Endogenous PCSK9 may influence circulating CD45NEG/CD34BRIGHT and CD45NEG/CD34BRIGHT/CD146NEG cells in patients with type 2 Diabetes Mellitus 103
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 101
PROGETTO DI SCREENING SU 24OOO SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI 101
Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial 100
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 100
An atypical etiology of ARDS: the importance of a careful eye in the evaluation. 99
Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases 99
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 99
A drug induced autoimmune hemolytic anemia: a case report. 97
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events 97
Totale 13.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022710 0 20 22 153 39 14 28 39 62 29 122 182
2022/20232.129 165 256 119 223 214 414 130 159 274 44 70 61
2023/20241.188 82 44 75 40 85 333 225 44 35 64 25 136
2024/20252.775 133 449 356 74 103 144 217 158 355 144 299 343
2025/20265.535 485 231 618 705 563 348 939 296 558 441 241 110
2026/2027141 134 7 0 0 0 0 0 0 0 0 0 0
Totale 16.994